To effectively prevent patients from nosocomial cross-infection and secondary infections, buffer wards for screening infectious patients who cannot be detected due to the incubation period are established in public hospitals in addition to isolation wards and general wards. In this paper, we consider two control mechanisms for three types of wards and patients: one is the dynamic bed allocation to balance the resource utilization among isolation, buffer, and general wards; the other is to effectively control the admission of arriving patients according to the evolution process of the epidemic to reduce mortality for COVID-19, emergency, and elective patients. Taking the COVID-19 pandemic as an example, we first develop a mixed-integer programming (MIP) model to study the joint optimization problem for dynamic bed allocation and patient admission control. Then, we propose a biogeography-based optimization for dynamic bed and patient admission (BBO-DBPA) algorithm to obtain the optimal decision scheme. Furthermore, some numerical experiments are presented to discuss the optimal decision scheme and provide some sensitivity analysis. Finally, the performance of the proposed optimal policy is discussed in comparison with the other different benchmark policies. The results show that adopting the dynamic bed allocation and admission control policy could significantly reduce the total operating cost during an epidemic. The findings can give some decision support for hospital managers in avoiding nosocomial cross-infection, improving bed utilization, and overall patient survival during an epidemic.
4 August 2022 in International Transactions in Operational Research
After over three years of COVID-19, it has become clear that infectious diseases are difficult to eradicate, and humans remain vulnerable under their influence in a long period. The presence of presymptomatic and asymptomatic patients is a significant obstacle to preventing and eliminating infectious diseases. However, the long-term transmission of infectious diseases involving asymptomatic patients still remains unclear. To address this issue, this paper develops a novel Markov process for infectious diseases with asymptomatic patients by means of a continuous-time level-dependent quasi-birth-and-death (QBD) process. The model accurately captures the transmission of infectious diseases by specifying several key parameters (or factors). To analyze the role of asymptomatic and symptomatic patients in the infectious disease transmission process, a simple sufficient condition for the stability of the Markov process of infectious diseases is derived using the mean drift technique. Then, the stationary probability vector of the QBD process is obtained by using RG-factorizations. A method of using the stationary probability vector is provided to obtain important performance measures of the model. Finally, some numerical experiments are presented to demonstrate the model's feasibility through analyzing COVID-19 as an example. The impact of key parameters on the system performance evaluation and the infectious disease transmission process are analyzed. The methodology and results of this paper can provide theoretical and technical support for the scientific control of the long-term transmission of infectious diseases, and we believe that they can serve as a foundation for developing more general models of infectious disease transmission.